The objectives of this study were (1) to develop a three-dimensional collagen/chitosan/glycosaminoglycan (GAG) scaffold in combination with transforming growth factor-beta1 (TGF-β1)-loaded chitosan microspheres, and (2) to evaluate the effect of released TGF-β1 on the chondrogenic potential of rabbit chondrocytes in such scaffolds. TGF-β1 was loaded into chitosan microspheres using an emulsion-crosslinking method. The controlled release of TGF-β1, as measured by enzyme-linked immunosorbent assay (ELISA), was monitored for 7 days. The porous scaffolds containing collagen and chitosan were fabricated by using a freeze drying technique and crosslinked using 1-ethyl-3-(3-dimethyl aminopropyl)carbodiimide (EDC) in the presence of chondroitin sulfate (CS), as a GAG component. The TGF-β1 microspheres were encapsulated into the scaffold at a concentration of 10ng TGF-β1/scaffold and then chondrocytes were seeded in the scaffold and incubated in vitro for 3 weeks. Both proliferation rate and glycosaminoglycan (GAG) production were significantly higher in the TGF-β1 microsphere-incorporated scaffolds than in the control scaffolds without microspheres. Extracellular matrix staining by Safranin O and immunohistochemistry for type II collagen were elevated in the scaffold with TGF-β1 microspheres. These results suggest that TGF-β1 microspheres when incorporated into a scaffold have the potential to enhance cartilage formation.
|Number of pages||11|
|Publication status||Published - 2004 Aug 1|
- Chondroitin sulfate
- TGF (transforming growth factor)
ASJC Scopus subject areas
- Biomedical Engineering